Biocon Bengaluru

Biocon falls nearly 6% on USFDA observations for Bengaluru facility

Following the drop in the stock price, the company's market valuation went down by Rs 2,202 crore to Rs 37,608 crore.

May 03, 2018, 17:15 PM IST